Browse the evidence

Sleeve gastrectomy can result in weight loss up to 23% at 1 year and is associated with a lower risk of malabsorption compared to Roux-en-Y gastric bypass.

Surgeons and healthcare providers should consider sleeve gastrectomy as a viable option for weight loss in transplant candidates.

Obesity is often associated with sleep disorders, which can lead to further obesity.

Addressing sleep quality may be crucial in obesity management strategies.

Diabetic nephropathy significantly increases cardiovascular risk.

Monitoring cardiovascular health is crucial for T2D patients with diabetic nephropathy.

Die Gewichtsentwicklung in den ersten Wochen bis Monaten nach Initialisierung einer Therapie ist der stärkste Prädiktor für Gewichtszunahme assoziiert mit AP und AD.

Monitoring weight in the early stages of treatment can help predict long-term outcomes.

Understanding factors associated with paraspinal muscle atrophy can help develop personalized rehabilitation protocols for postoperative recovery.

Practitioners can use these findings to tailor rehabilitation strategies for better recovery outcomes.

The Open Formulary group had a mean reduction in A1c of −2.7 ± 2.4, which was significantly greater than the Restrictive Formulary group's reduction of −0.74 ± 2.1.

Practitioners may consider that an open formulary can lead to better glycemic control in patients with type 2 diabetes.

The Open Formulary group had a modest weight reduction of −2.5 kg ± 4.4 kg.

Practitioners may note that an open formulary can also contribute to modest weight loss in patients.

Effective policies and strategies for the prevention of overweight and obesity are urgently required.

Policymakers should prioritize the development of effective obesity prevention strategies.

Obesity predicts cardiovascular disease mortality.

Practitioners should consider obesity as a significant risk factor for cardiovascular disease mortality.

Higher BMIs are associated with the development of chronic kidney disease.

Weight management may be crucial for preventing chronic kidney disease.

The association between adiposity and cardiovascular events is linear above specific BMI thresholds.

Understanding BMI thresholds can help in assessing cardiovascular risk.

The guidelines focus on cardiovascular risk stratification and management of cardiovascular risk factors in diabetes.

Practitioners should implement risk stratification and management strategies for cardiovascular health in diabetic patients.

The guidelines aim to reduce the risk of heart failure and chronic kidney disease in individuals with diabetes.

Practitioners should focus on strategies to mitigate the risk of heart failure and kidney disease in diabetic patients.

Obesity and diabetes mellitus are major risk factors for the development and progression of chronic kidney disease (CKD).

Healthcare providers should prioritize screening for CKD in patients with obesity and diabetes.

In patients with cardiovascular disease and diabetes mellitus, lower-extremity muscle strength is significantly associated with peak oxygen uptake (VO 2peak).

Practitioners should focus on improving lower-extremity muscle strength in patients with CVD and DM to enhance exercise capacity.

The interaction between diabetes mellitus and lower-extremity muscle strength significantly affects exercise capacity.

Understanding the interaction between diabetes and muscle strength can help tailor exercise programs for better outcomes.

The removal of amino acids during hemodialysis contributes substantially to protein malnutrition in patients.

Practitioners should ensure adequate protein intake for patients undergoing hemodialysis.

There was an overall improvement in the average BMI and weight of the participants despite the lack of statistical significance.

Improvements in BMI and weight may still occur, but practitioners should be cautious about interpreting these results as effective.

Continuous glucose monitoring (CGM) may be a useful tool for promoting dietary awareness and self-management among non-diabetic athletes.

Practitioners may consider using CGM to enhance dietary management in trained athletes.

Practical challenges with CGM device usability warrant attention.

Attention should be given to improving CGM usability to enhance user experience.

President Biden announced a strategy for ending hunger, increasing healthy eating and physical activity, and reducing diet-related diseases.

This indicates a national focus on improving public health through nutrition and physical activity initiatives.

More persons in the digital group reported to have achieved their current weight by linear weight loss (rapid or not) vs. through a series of weight loss cycles.

Practitioners may consider that digital participants tend to favor linear weight loss strategies.

There was a statistically significant Day × Cycle interaction for bloating, low-back pain, menstrual cramps, and stress, indicating a lower probability of experiencing these symptoms across the menstrual cycle during the intervention than the control cycle.

Yoga may significantly reduce common menstrual symptoms in athletic women.

Daily yoga was significantly associated with changes in perceived athletic performance across the menstrual cycle.

Implementing daily yoga may enhance perceived athletic performance in women during their menstrual cycle.